IL6 and diabetes mellitus: Notably, diabetes and obesity are always accompanied by chronic low‐grade inflammation [40, 42], but JTTZF significantly reduced pro‐inflammatory cytokines (IL‐1β, TNF‐α and IL‐6) in diabetic mouse livers.